TAK

Handel nachbörslich: 14.22 0.05 +0.35%

Takeda Pharmaceutical Co Adr (TAK)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Takeda Pharmaceutical Co Adr

Healthcare (1138)

@takedapharma

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TAK's Discussions on Twitter

Vergleichen Sie TAK mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TAK Takeda Pharmaceutical Co Adr	14.17	44.25B	29.96B	957.25M	4.77B	0.2956
ZTS Zoetis Inc	147.53	64.68B	9.39B	2.62B	2.22B	5.8121
HLN Haleon Plc Adr	9.20	41.19B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	19.61	21.74B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	421.04	18.93B	3.08B	1.24B	1.07B	25.61

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-02	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-03-16	Hochstufung	BofA Securities	Neutral → Buy
2022-07-19	Hochstufung	Cowen	Market Perform → Outperform
2021-10-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-04-19	Herabstufung	JP Morgan	Overweight → Neutral
2019-11-01	Eingeleitet	Cowen	Market Perform
2019-08-15	Herabstufung	Daiwa Securities	Outperform → Neutral

Alle ansehen

Takeda Pharmaceutical Co Adr Aktie (TAK) Neueste Nachrichten

Finanzdaten der Takeda Pharmaceutical Co Adr-Aktie (TAK)

Takeda Pharmaceutical Co Adr (TAK)

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Vergleichen Sie TAK mit anderen Aktien

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Takeda Pharmaceutical Co Adr Aktie (TAK) Neueste Nachrichten

CMBI Adds INNOVENT BIO (01801.HK) TP to $110.62 on Strategic Partnership with Takeda Pharmaceutical - AASTOCKS.com

BofAS Elevates INNOVENT BIO (01801.HK) TP to $113 as Co-op with Takeda Pharmaceutical Marks Major Step Towards Becoming Multinational Pharma Firm - AASTOCKS.com

CLSA Lifts INNOVENT BIO's TP to HKD120.1; Takeda Pharma Co-op Positive for Product Development - AASTOCKS.com

Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors - Placera.se

INNOVENT BIO Opens Up 10% on Shr Issuance to Takeda Pharma at ~30% Premium w/ Licensing Deal Worth USD11.4B - AASTOCKS.com

INNOVENT BIO Issues Shrs at ~30% Premium to Takeda Pharma w/ Licensing Deal Involving USD11.4B - AASTOCKS.com

Bank of America Upgraded, Allstate Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

TAK vs. DSNKY: Which Stock Is the Better Value Option? - MSN

Takeda Taps Nabla Bio's Generative AI Platform For Antibody Design In $1 Billion Pact - Benzinga

Walt Disney Upgraded, Southwest Airlines Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History - Yahoo

Pharma stocks in Asia fall as Trump announces 100% tariffs - Investing.com

5 Best High-Yield Dividend Stocks to Buy Now - The Motley Fool

Takeda’s narcolepsy drug shows positive results in phase 3 trials - Investing.com

U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease - Placera.se

Japan's Takeda weighs India for global trials to speed up drug launches - MSN

Takeda Pharmaceutical ADR Earns RS Rating Upgrade - MSN

IBD Rating Upgrades: Warrior Met Coal Shows Improved Technical Strength - inkl

IBD Rating Upgrades: Takeda Pharmaceutical ADR Shows Improved Technical Strength - MSN

IBD Rating Upgrades: Genmab ADR Shows Improved Relative Price Strength - inkl

Waltham biotech’s latest pharma deal valued at $2B - The Business Journals

TAK’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com

Blair William & Co. IL Cuts Stock Position in Takeda Pharmaceutical Co. (NYSE:TAK) - Defense World

VIS---In addition to collaborative drug discovery research with various partners, efforts to create a pipeline are being advanced. - 富途牛牛

Takeda Pharmaceutical Co ADR (TAK) Stock: A Year of Stock Market Dynamics - investchronicle.com

Asian ADRs Fall As Winners And Losers Stand Out - Finimize

The 30-day ADR trend, in yen terms, shows high values for Keyence, Kyocera Corporation Sponsored ADR, and Murata Manufacturing. - 富途牛牛

Takeda Pharma ADR earnings beat by $150.82, revenue fell short of estimates - Investing.com UK

On the 21st, ADR movements in yen terms showed high values for NISSAN MOTOR CO LTD, NINTENDO CO LTD, and Sumitomo Trust. - 富途牛牛

Why This Biotech's Dive Benefits Its Top Three Rivals - Investor's Business Daily

Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector (TAK) - Seeking Alpha

Behind Takeda Pharmaceutical Co ADR’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

Takeda stock rises after positive Phase 3 results for narcolepsy drug - Investing.com

Takeda stock rises after positive Phase 3 results for narcolepsy drug By Investing.com - Investing.com South Africa

Haleon PLC Sponsored ADR (NYSE:HLN) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World

Nomura Holdings Inc ADR (NYSE:NMR) Shares Acquired by GAMMA Investing LLC - Defense World

Hengan International Group (OTCMKTS:HEGIY) Stock Price Up 3.7% – Time to Buy? - Defense World

Finanzdaten der Takeda Pharmaceutical Co Adr-Aktie (TAK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie TAK